LexaGene Announces Non-Brokered Private Placement

LexaGene is pleased to announce it intends to complete a non-brokered private placement to raise up to $2,010,000 by the issuance of 6,700,000 units at $0.30 per unit.   Each unit will consist of one common share and one common share purchase warrant.  Each warrant will entitle the holder to acquire an additional common share for $0.60 per share for a three year period.


For Media Inquiries Contact

Gail Winslow

Director, Marketing

978 - 482 - 6237